Document is current

Article History

Received: 16 September 2024

Accepted: 6 February 2025

First Online: 19 March 2025

Declarations

:

: All participating centers to EPOCA study obtained approval from their respective ethics committee and consent/assent from parents/patients based on existing national regulations.

: Granted by all authors.

: MB, FR, YU, MT, PD and IRR have nothing to disclose. RN has received support for attending meetings and/or travel from SOBI. NR has received honoraria for consultancies or speaker bureaus from the following pharmaceutical companies in the past 3 years: 2 Bridge, Amgen, AstraZeneca, Aurinia, Bayer, Brystol Myers and Squibb, Celgene, inMed, Cambridge Healthcare Research, Domain Therapeutic, EMD Serono, Glaxo Smith Kline, Idorsia, Janssen, Eli Lilly, Novartis, Pfizer, Sobi, UCB. The IRCCS Istituto Giannina Gaslini (IGG), where NR works as full-time public employee, has received contributions from the following industries in the last 3 years: Bristol Myers and Squibb, Eli-Lilly, F Hoffmann-La Roche, Novartis, Pfizer, Sobi. This funding has been reinvested for the research activities of the hospital in a fully independent manner, without any commitment with third parties. AR has reports honoraria for consultancies or speaker bureaus (< 10.000 USD each) from AbbVie, Angelini, BMS, Pfizer, Hoffman LaRoche, Novartis, Pfizer, Reckitt Benckiser in the past 3 years. AR has received payment for expert testimony from Abbvie, Novartis, Pfizer in the past 3 years. AC reports Investigator initiated research grant from Pfizer and Alfa Sigma and speaker’s bureaus from Pfizer and Abbvie.